Početna stranicaSBHMY • OTCMKTS
add
Sino Biopharmaceutical Unsponsored Caymand Islands ADR
Preth. zaklj. cijena
7,75 $
Godišnji raspon
6,69 $ - 9,65 $
Tržišna kapitalizacija
53,96 mlr. HKD
Prosječna količina
58,00
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (CNY) | lip 2024.info | Godišnja promjena |
|---|---|---|
Prihod | 7,94 mlr. | 11,14 % |
Operativni troškovi | 4,78 mlr. | 10,58 % |
Neto dohodak | 1,51 mlr. | 139,69 % |
Neto profitabilnost | 19,01 | 115,78 % |
Zarada po dionici | — | — |
EBITDA | 1,98 mlr. | 8,88 % |
Efektivna porezna stopa | 16,99 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (CNY) | lip 2024.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 13,18 mlr. | −15,93 % |
Ukupna imovina | 66,70 mlr. | 1,62 % |
Ukupne obveze | 24,58 mlr. | −15,76 % |
Ukupni kapital | 42,12 mlr. | — |
Dionice u optjecaju | 18,21 mlr. | — |
Cijena prema knjigovodstvenoj vrijednosti | 4,31 | — |
Povrat imovine | 6,50 % | — |
Povrat kapitala | 8,37 % | — |
Tok novca
Neto promjena novca
| (CNY) | lip 2024.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 1,51 mlr. | 139,69 % |
Gotovina od poslovanja | 1,54 mlr. | 15,25 % |
Gotovina iz ulaganja | −1,02 mlr. | 49,91 % |
Gotovina iz financiranja | −2,05 mlr. | −1,42 % |
Neto promjena novca | −1,52 mlr. | 43,37 % |
Slobodan tok novca | 1,09 mlr. | 36,59 % |
Više
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
Glavni izvršni direktor
Osnovano
2000
Web-lokacija
Zaposlenici
24.437
